Results 31 to 40 of about 17,498 (264)

The Persistence of Population III Star Formation [PDF]

open access: yesMonthly Notices of the Royal Astronomical Society, 2018
We present a semi-analytic model of star formation in the early universe, beginning with the first metal-free stars. By employing a completely feedback-limited star formation prescription, stars form at maximum efficiency until the self-consistently calculated feedback processes halt formation.
Richard H Mebane   +2 more
openaire   +4 more sources

Understanding the Early Stages of Galaxy Formation Using Very Metal-poor Stars from the Hamburg/ESO Survey

open access: yesThe Astrophysical Journal, 2023
We explore the chemodynamical properties of a sample of very metal-poor (VMP) stars selected from the Hamburg/ESO survey, matched with Gaia EDR3, in the phase space identified by the three integrals of motion ( L _z , E , I _3 ). Disk and halo orbits are
Daniela Carollo   +3 more
doaj   +1 more source

Magnetohydrodynamics of Population III Star Formation [PDF]

open access: yesAIP Conference Proceedings, 2010
The evolution of collapsing primordial clouds and the formation of Population III (Pop III) protostars are investigated with three‐dimensional ideal MHD simulations. We follow the collapse of parsec‐sized primordial clouds down to the formation of protostars on sub‐AU scales.
Masahiro N. Machida   +5 more
openaire   +1 more source

The Impact of Patchy Reionization on Ultrafaint Dwarf Galaxies

open access: yesThe Astrophysical Journal, 2023
We investigate how patchy reionization affects the star formation history (SFH) and stellar metallicity of ultrafaint dwarf galaxies (UFDs). Patchy reionization refers to varying ultraviolet background strengths depending on a galaxy’s environment ...
Jaeeun Kim   +5 more
doaj   +1 more source

The Evolution of Population III and Extremely Metal-poor Binary Stars

open access: yesThe Astrophysical Journal, 2023
Numerical simulations have now shown that Population III (Pop III) stars can form in binaries and small clusters and that these stars can be in close proximity to each other.
Sung-Han Tsai   +4 more
doaj   +1 more source

Effects of axions on Population III stars [PDF]

open access: yesAstronomy & Astrophysics, 2017
10 pages, 11 figures, accepted for publication in A& ...
Choplin, Arthur   +5 more
openaire   +5 more sources

Type Ia Supernovae from First-generation Stars

open access: yesThe Astrophysical Journal
Type Ia supernovae (SNe Ia) discovered at redshift z ≲ 2.5 are presumed to be produced from Population I/II stars. In this work, we investigate the production of SNe Ia from Population III binaries in the cosmological framework.
Zhenwei Li   +3 more
doaj   +1 more source

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar   +7 more
wiley   +1 more source

LAP1-B is the First Observed System Consistent with Theoretical Predictions for Population III Stars

open access: yesThe Astrophysical Journal Letters
Recently, Nakajima et al. presented James Webb Space Telescope observations of the z = 6.6 Population III (Pop III) candidate LAP1-B, which is gravitationally lensed by galaxy cluster MACS J0416. We argue that this is the first object to agree with three
Eli Visbal, Ryan Hazlett, Greg L. Bryan
doaj   +1 more source

Rational Use of Herbal Products in Pediatric Patients Treated With Anticancer Drugs in the European Union

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction The use of herbal medical preparation (HMP) is rising among pediatric oncology patients, often to manage treatment‐related symptoms. Their effectiveness remains uncertain, and the risk of herb–drug interactions is underestimated.
Orianne Mahot   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy